Clinical Trial Update: Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial exploring cadonilimab with bevacizumab and chemotherapy for advanced non-squamous non-small cell lung cancer with untreated brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cadonilimab

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN